DRD
DRDGOLD LTD
$23.69
+0.13%
$2.0B
No data for this timeframe.
Vol
Market Cap$2.0B
Cap SizeMid Cap
Inst. Holders5 funds
Inst. Value$12.8M
Inst. Activity1 buys / 2 sells
Recent Activity
Inst.
RENAISSANCE TECHNOLOGIES LLC — TRIM
220,813 shares ($6.8M)
Inst.
BANK OF AMERICA CORP — TRIM
16,389 shares ($508.2K)
Price Targets
Historical data — last covering-analyst action Jan 2026. No current recommendation available.
$46.50 (Jan 2026)
Current $23.22
Low $46.50
Median $46.50
High $46.50
1 analysts
$46.50
$46.50
Analyst Ratings
0Strong Buy
1Buy
2Hold
4Sell
1Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jan 30, 2026 | HC Wainwright & Co. | MAINTAIN | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current FY | $2.21 ▲ +57.1% | $2.21 — $2.21 | 50% YoY | 1 |
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | $6.8M | TRIM |
| MORGAN STANLEY | $5.3M | TRIM |
| BANK OF AMERICA CORP | $508.2K | TRIM |
| WELLS FARGO & COMPANY/MN | $208.8K | DOUBLED |
| FMR LLC | $1.8K | TRIM |
5 institutional holders with $12.8M total value (413,485 shares) as of 2025-Q4. Top holders: RENAISSANCE, MORGAN, BANK. Net selling activity: 2 institutions trimmed/exited vs 1 added.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | RENAISSANCE TECHNOLOGIES LLC | 220,813 | $6.8M | 53.4% | TRIM -41.7% |
| 2 | MORGAN STANLEY | 169,493 | $5.3M | 41.0% | TRIM -34.7% |
| 3 | BANK OF AMERICA CORP /DE/ | 16,389 | $508.2K | 4.0% | TRIM -55.3% |
| 4 | WELLS FARGO & COMPANY/MN | 6,733 | $208.8K | 1.6% | DOUBLED +127.0% |
| 5 | FMR LLC | 57 | $1.8K | 0.0% | TRIM -54.4% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 378,913 | 220,813 | -41.7% | $6.8M | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | TRIM | 36,674 | 16,389 | -55.3% | $508.2K | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | DOUBLED | 2,966 | 6,733 | +127.0% | $208.8K | 2025-Q4 |
| UBS Group AG | ADD | 91,050 | 157,979 | +73.5% | $4.4M | 2025-Q3 |
| MORGAN STANLEY | TRIM | 227,723 | 148,620 | -34.7% | $4.1M | 2025-Q3 |
| WELLS FARGO & COMPANY/MN | NEAR_EXIT | 39,184 | 2,966 | -92.4% | $81.9K | 2025-Q3 |
| FMR LLC | TRIM | 125 | 57 | -54.4% | $1.6K | 2025-Q3 |
| TWO SIGMA INVESTMENTS, LP | EXIT | 26,700 | 0 | -100.0% | $0.00 | 2025-Q3 |
| MORGAN STANLEY | ADD | 168,885 | 227,723 | +34.8% | $3.0M | 2025-Q2 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 18,001 | 42,846 | +138.0% | $571.1K | 2025-Q2 |
| TWO SIGMA INVESTMENTS, LP | NEW | — | 26,700 | — | $355.9K | 2025-Q2 |
| MORGAN STANLEY | DOUBLED | 43,354 | 168,885 | +289.5% | $2.6M | 2025-Q1 |
| UBS Group AG | DOUBLED | 45,150 | 97,563 | +116.1% | $1.5M | 2025-Q1 |
| CITADEL ADVISORS LLC | TRIM | 113,252 | 64,200 | -43.3% | $993.2K | 2025-Q1 |
| WELLS FARGO & COMPANY/MN | DOUBLED | 1,641 | 43,778 | +2567.8% | $677.2K | 2025-Q1 |
| FMR LLC | TRIM | 257 | 152 | -40.9% | $2.4K | 2025-Q1 |
| MORGAN STANLEY | TRIM | 59,998 | 43,354 | -27.7% | $374.1K | 2024-Q4 |
| MORGAN STANLEY | TRIM | 83,464 | 59,998 | -28.1% | $578.4K | 2024-Q3 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Jan 2026): 13% buy across 8 analysts — 0 strong buy, 1 buy, 2 hold, 4 sell, 1 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Jan 2026. No current recommendation available.
$46.50 mean target (Jan 2026)
$46.50 Low
$46.50 High
| Metric | Value |
|---|---|
| Current Price | $23.22 |
| Target Low | $46.50 |
| Target Mean | $46.50 |
| Target Median | $46.50 |
| Target High | $46.50 |
| # Analysts | 1 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2026-06-30 |
$2.21 | $2.21 | $2.21 | 50.4% | +57.1% | 0↑ 1↓ | $0.7B | 46.1% | 1 |
| Next FY 2027-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $1.0B | 50.3% | — |
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jan 30, 2026 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 0 | 1 | 2 | 4 | 1 | 13% | |
| May 1, 2026 | 0 | 1 | 2 | 4 | 1 | 13% | |
| Apr 1, 2026 | 0 | 1 | 2 | 4 | 1 | 13% | |
| Mar 1, 2026 | 0 | 0 | 3 | 4 | 1 | 0% | |
| Feb 1, 2026 | 0 | 0 | 3 | 4 | 1 | 0% | |
| Jan 1, 2026 | 0 | 0 | 3 | 4 | 1 | 0% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.